Recent News

• 05.22.2025 - Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA
• 05.22.2025 - Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA
• 05.21.2025 - Codexis to Participate in Jefferies Global Healthcare Conference
• 05.21.2025 - Codexis to Participate in Jefferies Global Healthcare Conference
• 05.14.2025 - Codexis Reports First Quarter 2025 Financial Results
• 05.14.2025 - Codexis Reports First Quarter 2025 Financial Results
• 05.07.2025 - Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting
• 05.07.2025 - Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting
• 04.30.2025 - Codexis to Report First Quarter 2025 Financial Results on May 14
• 04.30.2025 - Codexis to Report First Quarter 2025 Financial Results on May 14

Recent Filings

• 05.14.2025 - 8-K Current report
• 05.14.2025 - EX-99.1 EX-99.1
• 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.29.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.24.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.24.2025 - DEF 14A Other definitive proxy statements
• 04.24.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.17.2025 - 4 Statement of changes in beneficial ownership of securities